Carlos Monteiro, Founder and CEO of Biojam reaffirms the pharmaceutical company's presence in the Iberian market, with a strategy to launch new solutions in Portugal and Spain, which also include the Benelux (Netherlands, Belgium, and Luxembourg).
Augusto Santos Costa, Director of Technical Affairs at Biojam presents the company's strategy regarding renal transplantation.